Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL19463957 | 0.92 | — | — | |
| Lactic Acid SCHEMBL28135832 | 0.92 | — | — | |
| Lactic Acid SCHEMBL4821907 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL19463679 | 0.92 | — | — | |
| Lactic Acid SCHEMBL28707219 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL27960791 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL27489945 | 0.92 | — | — | |
| Lactic Acid SCHEMBL2585781 | 0.92 | — | — | |
| Lactic Acid SCHEMBL20523337 | 0.92 | — | — | |
| Lactic Acid SCHEMBL5189465 | 0.92 | TP53 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114246953-B | Anti-cMet antibody drug conjugates and methods of use thereof | 艾伯维生物制药股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2023045802-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PEGYLATED EXENATIDE VARIANT AND USE THEREOF | 派格生物医药(苏州)股份有限公司 | 2023-03-30 | — | — | WO | claimed |
| CN-115845031-A | Pharmaceutical composition containing pegylated exenatide variant and application thereof | 派格生物医药(苏州)股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| EP-3837273-A1 | IMPROVED PROTEIN RECOVERY | Bristol-Myers Squibb Company (US) | 2021-06-23 | — | — | EP | claimed |
| US-20210171573-A1 | IMPROVED PROTEIN RECOVERY | BRISTOL-MYERS SQUIBB COMPANY | 2021-06-10 | — | — | US | claimed |
| CN-112566920-A | Improved protein recovery | 百时美施贵宝公司 | 2021-03-26 | — | — | CN | claimed |
| WO-2020036903-A1 | IMPROVED PROTEIN RECOVERY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-02-20 | — | — | WO | claimed |
| CN-107960637-A | The technique that production prepares lactic acid sodium powder | 河南金丹乳酸科技股份有限公司 | 2018-04-27 | — | — | CN | claimed |
| CN-103071146-A | Caspofungin acetate composition and preparation method thereof | BEIJING JESKONT PHARMACEUTICAL INTERNAT CO LTD | 2013-05-01 | — | — | CN | claimed |
| EP-4649088-A1 | IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2025-11-19 | — | — | EP | disclosed |
| EP-4608866-A1 | ANTIBODIES THAT BIND TO INTEGRIN ALPHA11 AND USES THEREOF | Fibrocor Therapeutics Inc. (CA) | 2025-09-03 | — | — | EP | disclosed |
| US-12043663-B2 | Anti-TNF-alpha-antibodies and functional fragments thereof | TILLOTTS PHARMA AG (CH) | 2024-07-23 | — | — | US | disclosed |
| WO-2024152014-A1 | FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| WO-2024151978-A1 | IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-0080879-B1 | PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON IN STABLE STATE | SUNSTAR KABUSHIKI KAISHA (JP) | 1986-10-01 | — | — | EP | disclosed |
| US-4605556-A | APPLYING INTERFERON, POLYHYDRIC SUGAR ALCOHOL, AND ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | disclosed |
| US-4605555-A | INTERFERON, POLYHYDRIC SUGAR ALCOHOL, ORGANIC ACID BUFFER | SUN STAR KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | disclosed |
| EP-0037667-B1 | IMMOBILIZED LACTASE, ITS PREPARATION AND USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-06-27 | — | — | EP | disclosed |
| EP-0080879-A2 | Pharmaceutical composition containing interferon in stable state | SUNSTAR KABUSHIKI KAISHA (JP) | 1983-06-08 | — | — | EP | disclosed |
| EP-0037667-A2 | Immobilized lactase, its preparation and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-14 | — | — | EP | disclosed |